Garrett D. Evers

Practices

• Corporate Transactions & Securities
• International
• Life Sciences

Professional Experience

Garrett is a partner in the firm's Corporate Transactions & Securities practice group. He focuses his practice on mergers and acquisitions; private equity and venture capital transactions; private placements of securities; securities offerings for publicly held companies; corporate organization and governance; state securities laws; and joint ventures. Garrett is the Chair of the firm's International Committee and is admitted to practice in the states of Ohio and New York.

Education

• University of Michigan, J.D., 1997
• The Johns Hopkins University, B.A., 1993, Phi Beta Kappa

• Private Equity / Venture Capital:
• On-going representation of medical device start-up companies including several rounds of angel and venture capital financing.
• On-going representation of private-equity fund in various transactions in the business services, media and telecommunications industries including fund-formation and numerous acquisitions and dispositions.
• Represented private-equity fund in combination of portfolio companies and related $195 million refinancing.
• Represented sellers in $100 million disposition of private-equity-backed specialty packaging company.
• Represented private-equity fund as majority shareholder in disposition of medical device company to a U.S. public company.
• Represented private-equity-backed powdered metal company in acquisition of Mexican business.
• Acquisition by private-equity fund of orthopedic implant manufacturer, representation of purchased company in several add-on acquisitions, and representation of sellers in sale of majority interest to another private-equity fund.
• Representation of start-up medical device manufacturer through first three rounds of equity financing, including sale of Series B Preferred Stock to two leading venture capital firms.
  
  
• Mergers and Acquisitions:
• Represented industry leading electronic waste recycler in company reorganization and recapitalization.
• Represented U.K. based precision optical components manufacturer in connection with U.S. based acquisitions and transactions.
• On-going representation of U.S. subsidiaries of Ireland based health services company.
• Represented U.S. public company in $1.5 billion sale of division with operations in the U.S. and 17 foreign countries.
• Represented Fortune 200 manufacturing company in the carve-out and disposition of a division with manufacturing operations in the U.S. and France.
• Represented management team in buy-out of polymer manufacturing entity.
• Represented plastic injection molding company in acquisition of Mexican and Canadian subsidiaries.
  
  
• Securities:
• Acted as underwriter's counsel in purchase and sale of newly issued convertible, redeemable preferred stock of Midwestern insurance company.
• Acted as issuer's counsel in securitization of over $1 billion worth of guaranteed and un-guaranteed student loans.
• Represented Fortune 250 company in connection with the issuance of euro- and yen- denominated notes.
• Represented U.S. public company in tender offer and purchase of outstanding shares of another U.S. public company.